-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, R8RPvxkuNZaxJCk+BkTAA5WAz/MLp3NZ4O5g/qP4o/GNpl1+TdpI1WsQjQC8mKQ8 0tO0+QaabOwuFC3wXjWU8g== 0001209191-10-044427.txt : 20100830 0001209191-10-044427.hdr.sgml : 20100830 20100830163122 ACCESSION NUMBER: 0001209191-10-044427 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100826 FILED AS OF DATE: 20100830 DATE AS OF CHANGE: 20100830 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Labinger Barry CENTRAL INDEX KEY: 0001332456 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14169 FILM NUMBER: 101047097 MAIL ADDRESS: STREET 1: 6791 BRENDAN COURT CITY: EDINA STATE: MN ZIP: 55439 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HUMAN GENOME SCIENCES INC CENTRAL INDEX KEY: 0000901219 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 223178468 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 14200 SHADY GROVE ROAD CITY: ROCKVILLE STATE: MD ZIP: 20850-3338 BUSINESS PHONE: 3013098504 MAIL ADDRESS: STREET 1: 14200 SHADY GROVE ROAD CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2010-08-26 0 0000901219 HUMAN GENOME SCIENCES INC HGSI 0001332456 Labinger Barry 14200 SHADY GROVE ROAD ROCKVILLE MD 20850 0 1 0 0 Exec VP & CCO Common Stock 2010-08-26 4 M 0 13050 4.92 A 13050 D Common Stock 2010-08-26 4 S 0 13050 28.5334 D 0 D Common Stock 2010-08-27 4 M 0 16079 4.92 A 16079 D Common Stock 2010-08-27 4 S 0 16079 28.5022 D 0 D Employee Stock Option - Right to Buy 4.92 2010-08-26 4 M 0 13050 0.00 D 2018-03-10 Common Stock 13050 136950 D Employee Stock Option - Right to Buy 4.92 2010-08-27 4 M 0 16079 0.00 D 2018-03-10 Common Stock 16079 120871 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and Charles Schwab effective 6/16/10. This transaction was executed in multiple trades at prices ranging from $28.50 to $28.54. The price reported above reflects the weighted average sales price. Upon written request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price is available. This transaction was executed in multiple trades at prices ranging from $28.50 to $28.51. The price reported above reflects the weighted average sales price. Upon written request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price is available. One-eigth of the 150,000 options granted on March 10, 2008, vested on the six-month anniversary date (September, 2008) and the remaining options granted vested and continue to vest monthly on a ratable basis for the next 42 months commencing on October 10, 2008. /James H. Davis- Pursuant Power of Attorney 2010-08-30 -----END PRIVACY-ENHANCED MESSAGE-----